449 related articles for article (PubMed ID: 33739550)
1. Spatial correlation maps of the hippocampus with cerebrospinal fluid biomarkers and cognition in Alzheimer's disease: A longitudinal study.
Liu G; Liu C; Qiu A;
Hum Brain Mapp; 2021 Jun; 42(9):2931-2940. PubMed ID: 33739550
[TBL] [Abstract][Full Text] [Related]
2. One-year Follow-up Study of Hippocampal Subfield Atrophy in Alzheimer's Disease and Normal Aging.
Madusanka N; Choi HK; So JH; Choi BK; Park HG
Curr Med Imaging Rev; 2019; 15(7):699-709. PubMed ID: 32008518
[TBL] [Abstract][Full Text] [Related]
3. The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.
Hohman TJ; Bell SP; Jefferson AL;
JAMA Neurol; 2015 May; 72(5):520-9. PubMed ID: 25751166
[TBL] [Abstract][Full Text] [Related]
4. Volume changes of hippocampal and amygdala subfields in patients with mild cognitive impairment and Alzheimer's disease.
Qu H; Ge H; Wang L; Wang W; Hu C
Acta Neurol Belg; 2023 Aug; 123(4):1381-1393. PubMed ID: 37043115
[TBL] [Abstract][Full Text] [Related]
5. Hippocampal Stratum Radiatum, Lacunosum, and Moleculare Sparing in Mild Cognitive Impairment.
Su L; Hayes L; Soteriades S; Williams G; Brain SAE; Firbank MJ; Longoni G; Arnold RJ; Rowe JB; O'Brien JT
J Alzheimers Dis; 2018; 61(1):415-424. PubMed ID: 29171994
[TBL] [Abstract][Full Text] [Related]
6. Hippocampal subfield volumes in mild cognitive impairment and alzheimer's disease: a systematic review and meta-analysis.
Zhang J; Xie L; Cheng C; Liu Y; Zhang X; Wang H; Hu J; Yu H; Xu J
Brain Imaging Behav; 2023 Dec; 17(6):778-793. PubMed ID: 37768441
[TBL] [Abstract][Full Text] [Related]
7. Role of hippocampal subfields in neurodegenerative disease progression analyzed with a multi-scale attention-based network.
Xu H; Liu Y; Wang L; Zeng X; Xu Y; Wang Z
Neuroimage Clin; 2023; 38():103370. PubMed ID: 36948139
[TBL] [Abstract][Full Text] [Related]
8. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
[TBL] [Abstract][Full Text] [Related]
9. Atrophy asymmetry in hippocampal subfields in patients with Alzheimer's disease and mild cognitive impairment.
Jahanshahi AR; Naghdi Sadeh R; Khezerloo D
Exp Brain Res; 2023 Feb; 241(2):495-504. PubMed ID: 36593344
[TBL] [Abstract][Full Text] [Related]
10. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
[TBL] [Abstract][Full Text] [Related]
11. Non-linear registration improves statistical power to detect hippocampal atrophy in aging and dementia.
Bartel F; Visser M; de Ruiter M; Belderbos J; Barkhof F; Vrenken H; de Munck JC; van Herk M;
Neuroimage Clin; 2019; 23():101902. PubMed ID: 31233953
[TBL] [Abstract][Full Text] [Related]
12. White matter hyperintensities are associated with disproportionate progressive hippocampal atrophy.
Fiford CM; Manning EN; Bartlett JW; Cash DM; Malone IB; Ridgway GR; Lehmann M; Leung KK; Sudre CH; Ourselin S; Biessels GJ; Carmichael OT; Fox NC; Cardoso MJ; Barnes J;
Hippocampus; 2017 Mar; 27(3):249-262. PubMed ID: 27933676
[TBL] [Abstract][Full Text] [Related]
13. Functional signature of conversion of patients with mild cognitive impairment.
Delli Pizzi S; Punzi M; Sensi SL;
Neurobiol Aging; 2019 Feb; 74():21-37. PubMed ID: 30408719
[TBL] [Abstract][Full Text] [Related]
14. Distinct Atrophy Pattern of Hippocampal Subfields in Patients with Progressive and Stable Mild Cognitive Impairment: A Longitudinal MRI Study.
Zeng Q; Li K; Luo X; Wang S; Xu X; Li Z; Zhang T; Liu X; Fu Y; Xu X; Wang C; Wang T; Zhou J; Liu Z; Chen Y; Huang P; Zhang M;
J Alzheimers Dis; 2021; 79(1):237-247. PubMed ID: 33252076
[TBL] [Abstract][Full Text] [Related]
15. Sex differences in the association between AD biomarkers and cognitive decline.
Koran MEI; Wagener M; Hohman TJ;
Brain Imaging Behav; 2017 Feb; 11(1):205-213. PubMed ID: 26843008
[TBL] [Abstract][Full Text] [Related]
16. Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers.
Da X; Toledo JB; Zee J; Wolk DA; Xie SX; Ou Y; Shacklett A; Parmpi P; Shaw L; Trojanowski JQ; Davatzikos C;
Neuroimage Clin; 2014; 4():164-73. PubMed ID: 24371799
[TBL] [Abstract][Full Text] [Related]
17. Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum.
Allison SL; Koscik RL; Cary RP; Jonaitis EM; Rowley HA; Chin NA; Zetterberg H; Blennow K; Carlsson CM; Asthana S; Bendlin BB; Johnson SC
Neuroimage Clin; 2019; 23():101895. PubMed ID: 31252287
[TBL] [Abstract][Full Text] [Related]
18. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
[TBL] [Abstract][Full Text] [Related]
19. The Trajectory of Cerebrospinal Fluid Growth-Associated Protein 43 in the Alzheimer's Disease Continuum: A Longitudinal Study.
Zhang H; Lyu D; Jia J;
J Alzheimers Dis; 2022; 85(4):1441-1452. PubMed ID: 34958042
[TBL] [Abstract][Full Text] [Related]
20. Hippocampal Subfield Atrophies in Converted and Not-Converted Mild Cognitive Impairments Patients by a Markov Random Fields Algorithm.
Vasta R; Augimeri A; Cerasa A; Nigro S; Gramigna V; Nonnis M; Rocca F; Zito G; Quattrone A; For The Alzheimer's Disease Neuroimaging Initiative
Curr Alzheimer Res; 2016; 13(5):566-74. PubMed ID: 26787291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
